ArticleIEEE open journal of engineering in medicine and biology2024
EmRad: Ubiquitous Vital Sign Sensing Using Compact Continuous-Wave Radars.
Article in IEEE open journal of engineering in medicine and biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Contactless Sleep Staging With Radar: A Transfer Learning Approach.IEEE open journal of engineering in medicine and biology · 2026Article
- A Novel Scheme for High-Accuracy Frequency Estimation in Non-Contact Heart Rate Detection Based on Multi-Dimensional Accumulation and FIIB.Sensors (Basel, Switzerland) · 2025Article
- The EmpkinS-EKSpression Reappraisal Training Augmented With Kinesthesia in Depression: One-Armed Feasibility Study.JMIR formative research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In biomedical monitoring, non-intrusive and continuous tracking of vital signs is a crucial yet challenging objective. Although accurate, traditional methods, such as electrocardiography (ECG) and photoplethysmography (PPG), necessitate direct contact with the patient, posing limitations for long-term and unobtrusive monitoring. To address this challenge, we introduce the EmRad system, an innovative solution harnessing the capabilities of continuous-wave (CW) radar technology for the contactless detection of vital signs, including heart rate and respiratory rate. EmRad discerns itself by emphasizing miniaturization, performance, scalability, and its ability to generate large-scale datasets in various environments. This article explains the system's design, focusing on signal processing strategies and motion artifact reduction to ensure precise vital sign extraction. The EmRad system's versatility is showcased through various case studies, highlighting its potential to transform vital sign monitoring in research and clinical contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.